Pfizer submits data to US FDA for 2nd Covid booster in older adults
New York : US drug maker Pfizer has announced that it has submitted an application to the US Food and Drug Administration (FDA) for emergency use authorisation (EUA) of an additional booster dose for adults 65 years of age and older who…